BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2008
View Archived Issues
Positive first-in-human results of Novartis' ATF-936 for the treatment of osteoporosis
Read More
Glucosamine analogue GN-1 has in vivo antiarthritic activity
Read More
Peptide vaccine ATX-MS-1467 safe and well tolerated in MS patients
Read More
Benefit of alefacept in moderate to severe atopic eczema
Read More
A.P. Pharma highlights positive phase III APF-530 results in preventing CINV
Read More
VaxInnate advances second flu vaccine candidate into clinical development
Read More
Prasugrel NDA review not yet completed
Read More
Indevus and FDA agree on data requirement for Nebido resubmission
Read More
Indevus and Teva sign agreement for pagoclone
Read More
IND submission for HA-Irinotecan
Read More
Shionogi extends HuCAL license agreement with MorphoSys
Read More
Cancer Research UK and Astex to develop new cancer treatment
Read More
Daiichi delays Japanese launch of pediatric influenza vaccine ActHIB until December 2008
Read More
FDA extends PDUFA action date for Ipsen's BLA for Dysport in cervical dystonia
Read More
Astellas submits sNDA to Japanese PMDA for Prograf in myasthenia gravis
Read More
Novel antiinfective agents disclosed in recent MicuRx and GSK patents
Read More
European Commission grants orphan drug status to Enzon's Oncaspar-IV
Read More
Recent Tibotec patents report novel therapeutic agents for HCV infection
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More
Bayer's novel anticoagulant Xarelto receives European approval
Read More
European Commission adopts EMEA recommendations for Arcoxia 90 mg
Read More
Idera reports preliminary data from phase IIa IMO-2055 trial in RCC
Read More
Lilly initiates second global phase III trial for LY-450139 in AD
Read More
Ore Pharmaceuticals initiates clinical trial of ACE2 enzyme inhibitor GL-1001
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Sangamo BioSciences
Read More
Tranzyme presents positive phase IIb results for ghrelin agonist TZP-101
Read More
Uric acid, a novel therapeutic approach in the treatment of acute stroke
Read More